GlassScriptPhysician profile
Mostafa Tabassomi
NPI 1003042342
$32,757.94
in general payments reported to CMS, 2019-2025
34 companies · $7,087 in 2025
The $7,087 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $185 · 2021: $443 · 2022: $1,378 · 2023: $11K · 2024: $12K · 2025: $7,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $5,045 · Travel and Lodging: $1,008 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Food and Beverage | $5,045.28 |
| Travel and Lodging | $1,008.33 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,517.85 | 2023-2025 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $1,320.14 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,176.31 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $989.78 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Insmed, INC. | $685.96 | 2019-2025 | Arikayce, Brinsupri |
| Galvanize Therapeutics, INC | $288.50 | 2025 | Aliya System |
| Regeneron Healthcare Solutions, INC. | $288.40 | 2021-2025 | Dupixent |
| Electromed, INC. | $259.72 | 2022-2025 | Smartvest |
| Inari Medical, INC. | $211.02 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $180.09 | 2022-2024 | Verquvo, Belsomra, Dificid |
| Shionogi INC | $168.51 | 2021-2022 | |
| Amgen INC. | $155.25 | 2023-2024 | Tezspire |
| Mylan Specialty L.P. | $135.24 | 2019-2024 | Yupelri |
| Siemens Medical Solutions USA, INC. | $128.94 | 2024 | |
| Grifols USA, LLC | $127.62 | 2024-2025 | Prolastin-C Liquid |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $124.08 | 2019-2024 | Photofrin |
| Janssen Pharmaceuticals, INC | $119.96 | 2021-2024 | Xarelto |
| Abbvie INC. | $108.57 | 2022-2025 | Dalvance |
| Pulmonx Corporation | $93.01 | 2019-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $86.01 | 2022-2023 | Acthar |
| Advanced Respiratory, INC | $76.59 | 2019-2021 | |
| Olympus America INC. | $61.58 | 2024 | Single-Use Flexible Video Bronchoscope, Spiration Valve System |
| Smith+Nephew, INC. | $58.77 | 2023-2025 | Grafix, Grafix Pl |
| Genzyme Corporation | $54.41 | 2025 | |
| Philips North America LLC | $53.57 | 2022-2023 | |
| Cook Medical LLC | $47.68 | 2025 | Echotip Procore |
| Baxter Healthcare | $45.69 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $38.91 | 2019 | |
| Viatris Specialty LLC | $29.92 | 2025 | Yupelri |
| Abbott Laboratories | $28.47 | 2023 | Freestyle Libre 2 |
| Inspire Medical Systems, INC. | $27.49 | 2023 | Inspire |
| Eisai INC. | $25.97 | 2021 | |
| La Jolla Pharmaceutical Company | $23.93 | 2019 | |
| Erbe USA INC | $20.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mostafa Tabassomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.